As technologies evolve and healthcare innovation accelerates, the traditional boundaries separating medtech, big tech, and big pharma are increasingly blurry—but the cultural and strategic gaps between them remain. At LSI USA ’25, panelists Juan-Pablo Mas (Action Potential Venture Capital), Nishant Doctor (Surf Therapeutics), and Jordi Parramon (Nexus NeuroTech Ventures) joined moderator Katie Elias to examine how medtech can better align with big tech and big pharma to drive innovation forward. This blog is originally published here: https://www.lsiusasummit.com/news/big-tech-and-big-pharma-how-medtech-can-bridge-the-gap